STOCK ALARM
PRO
SA
PRO
Menu
Explore
News
Screener
Alerts
⌘K
⌘J
Pro
Sign In
Free Account
Themes
Alnylam Pharmaceuticals, Inc.
ALNY
NASDAQ
Loading
Overview
Intelligence
Charts
News
Fundamentals
Key Metrics
Financials
Growth
Insiders
Analysis
More
Key Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Loading chart...
As of
2025
• vs 2024
Annual
Quarterly
Core Metrics
Market Cap
$52.09B
+73.4%
P/E Ratio
166.04
+253.8%
P/S Ratio
14.03
+5.0%
ROE
39.76%
+109.6%
ROIC
13.74%
+438.0%
FCF Yield
0.89%
+730.1%
Debt/Equity
1.62
-96.0%
Current Ratio
2.76
-0.6%
Interest Coverage
1.99x
+259.2%
Per Share
Revenue/Share
$28.35
+61.0%
Net Income/Share
$2.39
+209.9%
Operating CF/Share
$4.00
+6243.7%
Free CF/Share
$3.55
+1164.8%
Cash/Share
$22.20
+5.2%
Book Value/Share
$6.02
+1046.2%
Tangible Book/Share
$6.02
+1046.2%
Equity/Share
$6.02
+1046.2%
Interest Debt/Share
$11.69
-48.3%
Valuation
Market Cap
$52.09B
+73.4%
Enterprise Value
$51.71B
+62.6%
P/E Ratio
166.04
+253.8%
P/S Ratio
14.03
+5.0%
P/OCF Ratio
99.40
+102.8%
P/FCF Ratio
111.94
+115.9%
P/B Ratio
66.01
-85.3%
P/TB Ratio
66.01
-85.3%
EV/Sales
13.92
-1.6%
EV/EBITDA
92.81
+152.2%
Profitability
Earnings Yield
0.60%
+165.0%
FCF Yield
0.89%
+730.1%
ROE
39.76%
+109.6%
ROIC
13.74%
+438.0%
Return on Tangible Assets
6.32%
+196.3%
Capital Allocation
CapEx/OCF
11.20%
+102.7%
CapEx/Revenue
1.58%
+3.7%
CapEx/Depreciation
1.05
+74.4%
SBC/Revenue
9.38%
-22.5%
Balance Sheet
Debt/Equity
1.62
-96.0%
Debt/Assets
0.26
-60.2%
Net Debt/EBITDA
-0.68
+93.2%
Current Ratio
2.76
-0.6%
Interest Coverage
1.99x
+259.2%
Income Quality
1.67
+5489.9%
Efficiency
Days Sales Outstanding
76 days
+16.1%
Days Payables Outstanding
62 days
-37.5%
Days Inventory
45 days
-49.7%
Receivables Turnover
4.78x
-13.9%
Payables Turnover
5.85x
+60.0%
Inventory Turnover
8.19x
+98.8%
Special Valuations
Graham Number
$18.02
Graham Net-Net
$-4.92
+44.7%